F. Waechter
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 8
- Pharmacology 16
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 7
- Co-authors
- P. Bentley (16 shared papers)W. Stäubli (17 shared papers)J Fabre (1 shared paper)Nicolas Carrère (1 shared paper)P Maurel (1 shared paper)Jean‐Marc Pascussi (1 shared paper)Sabine Gerbal‐Chaloin (1 shared paper)Lydiane Pichard‐Garcia (1 shared paper)
- Journals
- Toxicology in Vitro (3 papers)Carcinogenesis (2 papers)Experimental Cell Research (2 papers)Toxicology and Applied Pharmacology (2 papers)Toxicological Sciences (2 papers)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
F. Waechter
31 papers receiving 730 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 354
- Biochemistry 101
- Hepatology 55
- Oncology 191
- Cancer Research 102
Countries citing papers authored by F. Waechter
This map shows the geographic impact of F. Waechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Waechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Waechter more than expected).
Fields of papers citing papers by F. Waechter
This network shows the impact of papers produced by F. Waechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Waechter. The network helps show where F. Waechter may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Waechter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of CYP2C genes in human hepatocytes in primary culture. | 2001 | 259 |
| 2 | 2007 | 80 | |
| 3 | 1987 | 59 | |
| 4 | 1997 | 44 | |
| 5 | 1982 | 41 | |
| 6 | 1977 | 32 | |
| 7 | 1994 | 30 | |
| 8 | 2003 | 28 | |
| 9 | 1979 | 26 | |
| 10 | 1988 | 19 | |
| 11 | 1986 | 16 | |
| 12 | 1999 | 15 | |
| 13 | 1988 | 14 | |
| 14 | 1990 | 12 | |
| 15 | 1988 | 11 | |
| 16 | 1988 | 11 | |
| 17 | 1982 | 10 | |
| 18 | 1987 | 9 | |
| 19 | 1990 | 9 | |
| 20 | 1980 | 6 |
About F. Waechter
F. Waechter is a scholar working on Molecular Biology, Pharmacology, Oncology, Biochemistry and Cancer Research, having authored 31 papers that have together received 778 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Carcinogens and Genotoxicity Assessment (5 papers), Metabolism and Genetic Disorders (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Pharmacology (354 citations), Biochemistry (101 citations), Hepatology (55 citations), Oncology (191 citations) and Cancer Research (102 citations). F. Waechter has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include P. Bentley, W. Stäubli, J Fabre, Nicolas Carrère, P Maurel, Jean‐Marc Pascussi, Sabine Gerbal‐Chaloin, Lydiane Pichard‐Garcia, F. Bieri and Samar F. Muakkassah-Kelly. Their work appears in journals such as Toxicology in Vitro, Carcinogenesis, Experimental Cell Research, Toxicology and Applied Pharmacology and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.